The Republican-backed legislation targets specific dyes and preservatives linked to health concerns following California's ...

Alterity Therapeutics is aiming to shift the narrative for patients with Multiple System Atrophy with its lead drug ATH434. .

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

The Food and Drug Administration announced the recall of tens of thousands of cases of deodorant. The FDA said that it was ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

The FDA did not provide a reason for the recall, but said the products had a cGMP (Current Good Manufacturing Practices) ...

The Food and Drug Administration has recalled more than 67,000 cases of deodorant sold at major retailers due to manufacturing practices that violate federal regulations.

(Reuters) -Children's Hospital Los Angeles, citing recent U.S. Food and Drug Administration actions, on Monday said it has paused usage of Sarepta Therapeutics' gene therapy Elevidys in all patients ...